CNC
Centene CorporationNYSEHealthcare$35.10+3.39%OpenMarket Cap: $17.26B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.86
P/S
0.09
EV/EBITDA
-3.53
DCF Value
$261.84
FCF Yield
25.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
12.2%
Operating Margin
-3.9%
Net Margin
-3.4%
ROE
-27.7%
ROA
-10.7%
ROIC
-13.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $49.73B | 15.2% | $-1.74B | $-1.10B | $-2.24 | — |
| FY 2025 | $194.78B | 12.2% | $-7.62B | $-6.67B | $-13.62 | — |
| Q3 2025 | $49.69B | 16.4% | $-6.95B | $-6.63B | $-13.50 | — |
| Q2 2025 | $48.74B | 6.0% | $-458.0M | $-253.0M | $-0.51 | — |
| Q1 2025 | $46.62B | 11.2% | $1.53B | $1.31B | $2.63 | — |
| Q4 2024 | $40.80B | 9.1% | $175.0M | $283.0M | $0.56 | — |
| FY 2024 | $163.07B | 10.3% | $3.17B | $3.31B | $6.31 | — |
| Q3 2024 | $42.02B | 9.6% | $665.0M | $713.0M | $1.36 | — |
| Q2 2024 | $39.84B | 11.1% | $1.23B | $1.15B | $2.16 | — |
| Q1 2024 | $40.41B | 11.5% | $1.11B | $1.16B | $2.16 | — |
| Q4 2023 | $39.46B | 9.3% | $-194.0M | $45.0M | $0.08 | — |
| FY 2023 | $154.00B | 11.2% | $2.93B | $2.70B | $4.95 | — |